|By Marketwired .||
|May 13, 2014 06:00 AM EDT||
STOCKHOLM, SWEDEN -- (Marketwired) -- 05/13/14 -- Greenleaf Medical AB announced that the company was issued patent #8,642,098 from the U.S. Patent and Trademark Office (USPTO) for their innovation in health science.
The new patent, "Use of plant cell membrane for the treatment of obesity," issued to Greenleaf Medical AB relates to the use of at least one cell membrane fraction to help retard fat digestion, suppress appetite, body weight and/or lower blood lipids. Greenleaf Medical AB's Appethyl uses thylakoids (a pigmented membrane found in spinach) to significantly reduce appetite and help induce weight loss.
Appethyl is the trade name for the clinically tested appetite suppression product from spinach that is being brought to the marketplace by Greenleaf Medical (GLM), a Swedish company that has licensed the patented technology from Lund University in Sweden. Five human studies and two animal trials conducted in 2013 have affirmed both the appetite suppression and weight loss effects found in the original pilot trials. There are now six completed clinical trials ranging from mechanism of action and acute appetite suppression to significant weight loss in double-blind, placebo-controlled clinical studies.
"In addition to the strong scientific background of Appethyl, the U.S. Patent provides confidence for both our distributors and our customers. This is perfect timing for our upcoming U.S. launch," said Dan Edwall, chairman of the board of Greenleaf Medical AB.
Greenleaf Medical AB is currently awaiting approval on three patents including the process patent, as well as patents related to reducing absorption of sugar and one related to prebiotic effects.
The "Use of plant cell membrane for the treatment of obesity" patent is in addition to others that Greenleaf Medical AB has been issued in Korea and Australia. Greenleaf Medical AB owns full worldwide exclusivity for these patents, which have been issued to Thylabisco AB.
For more information on Appethyl or Greenleaf Medical AB, please visit http://www.gl-medical.com or contact Maria Soderberg at +46 70 869 27 06, (GMT +1) email: ms(at)gl-medical(dot)com.
About Greenleaf Medical AB
Greenleaf Medical is a Swedish research and development company, active in the global nutraceutical market, which sells and develops natural ingredients with well-documented, beneficial health effects. Greenleaf Medical works together with universities and international science and regulatory groups. Their products are used in both Functional Food and Dietary Supplements.
Greenleaf Medical believes the secret of health and beauty is based on finding the best ingredients through scientific validation. Dedicated to creating natural products with published mechanism-of-action and efficacy studies, the Greenleaf Medical team believes in the unique composition of natural, active ingredients and innovative formula of their supplements.
Cloud Expo, Inc. has announced today that Andi Mann returns to 'DevOps at Cloud Expo 2017' as Conference Chair The @DevOpsSummit at Cloud Expo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great t...
Dec. 10, 2016 03:45 PM EST Reads: 867
Rapid innovation, changing business landscapes, and new IT demands force businesses to make changes quickly. In the eyes of many, containers are at the brink of becoming a pervasive technology in enterprise IT to accelerate application delivery. In this presentation, attendees learned about the: The transformation of IT to a DevOps, microservices, and container-based architecture What are containers and how DevOps practices can operate in a container-based environment A demonstration of how ...
Dec. 10, 2016 03:45 PM EST Reads: 1,296
Dec. 10, 2016 03:30 PM EST Reads: 890
Dec. 10, 2016 02:45 PM EST Reads: 1,229
Dec. 10, 2016 02:45 PM EST Reads: 869
Dec. 10, 2016 02:30 PM EST Reads: 2,043
Dec. 10, 2016 01:45 PM EST Reads: 666
Dec. 10, 2016 01:00 PM EST Reads: 393
Dec. 10, 2016 01:00 PM EST Reads: 1,240
Dec. 10, 2016 12:45 PM EST Reads: 2,137
Dec. 10, 2016 12:30 PM EST Reads: 1,967
Dec. 10, 2016 12:15 PM EST Reads: 7,468
Dec. 10, 2016 12:15 PM EST Reads: 2,284
Dec. 10, 2016 12:00 PM EST Reads: 1,096
Dec. 10, 2016 12:00 PM EST Reads: 2,400